Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Thrombin
    (1)
  • Thrombopoietin Receptor
    (1)
  • Others
    (2)
Filter
Search Result
Results for "

megakaryocytopoiesis

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    3
    TargetMol | Inhibitors_Agonists
Avatrombopag
YM477, AKR-501, E5501
T7417570406-98-3
Avatrombopag (YM477) is a new oral thrombopoietin (TPO) receptor agonist, activating TPO receptor and increasing megakaryocytic proliferation differentiation and platelet production.
  • Inquiry Price
Size
QTY
TPO agonist 1
T171461033040-23-1
TPO agonist 1, a thrombopoietin agonist, is useful as a promoter of thrombopoiesis and megakaryocytopoiesis for the treatment of thrombocytopenia.
  • Inquiry Price
6-8 weeks
Size
QTY
Avatrombopag maleate
T68888677007-74-8
Avatrombopag, also known as AKR-501, YM477, AS 1670542 or E5501, is a novel orally-active thrombopoietin (TPO) receptor agonist. AKR-501 specifically targeted the TPO receptor and stimulated megakaryocytopoiesis throughout the development and maturation of megakaryocytes just as rhTPO did. AKR-501 may be useful in the treatment of patients with thrombocytopenia. Avatrombopag was first approved in 2018.
  • Inquiry Price
1-2 weeks
Size
QTY